AMIXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31

Autonomix Medical, Inc.

Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026

$2.65−0.20 (-6.85%)

Close on Oct 19, 2026

Market cap: $1.44M
P/E (TTM): –
Dividend yield: –

Autonomix Medical, Inc. income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2026 2026-03-31	FY 2025 2025-03-31	FY 2024 2024-03-31	FY 2023 2023-03-31
Revenue	0	0	0	0
Research & Development	7.14	4.73	2.23	0.75
General & Administrative	9.89	6.86	5.25	1.25
Advertising Expenses	0	0.10	1.80	0.10
Operating Expenses	17	12	12	1.99
Operating Income	-17	-12	-12	-1.99
Interest Expense	0	0.18	0.08	0
Interest & Investment Income	0.32	0.35	0.13	0
Other Non-Operating Income	0.32	0.18	-3.40	0
Pretax Income	-17	-11	-15	-1.99
Income Tax Expense	0	0	0	0
Net Income	-17	-11	-15	-1.99
EPS (Basic)(per share)	-2.32	-6.46	-14.82	-2.30
Shares Outstanding (Basic, Weighted)(shares)	7.22	1.77	1.04	0.89
Shares Outstanding (Diluted, Weighted)(shares)	7.22	1.77	1.04	0.89
EBITDA	-17	-11	-12	-1.99

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2026: -238.9%

Financial strength

Current ratio: 4.85
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 423.0%

Valuation

P/E ratio: –
Price to sales: –
Price to book: 0.46
Dividend yield: –